acetyl-l-carnitine biological half-life in chronic pain: A narrative review Acetyl-carnitine improves hyperactivity and learning

A six-month Phase IIb study involved 247 patients with steatohepatitis who received 800 or 1200 mg/day of the drug

[0585] In certain embodiments methods of cellular therapy are provided where the cellular therapy utilizes cells (e.g., immunomodulatory cells such as T cells) genetically modified to express a CAR as described herein and the CAR expressing cell (e.g., CAR T cell) is infused to a recipient in need thereof

Incidental Lewy body disease: do some cases represent a preclinical stage of dementia with Lewy bodies

[DOI] [PubMed] [Google Scholar] 65.Kuwasawa-Iwasaki M., Io H., Muto M., Ichikawa S., Wakabayashi K., Kanda R., Nakata J., Nohara N., Tomino Y., Suzuki Y